180 related articles for article (PubMed ID: 25954441)
1. A Comparison of Data Driven-based Measures of Adherence to Oral Hypoglycemic Agents in Medicaid Patients.
Zhu VJ; Tu W; Rosenman MB; Overhage JM
AMIA Annu Symp Proc; 2014; 2014():1294-301. PubMed ID: 25954441
[TBL] [Abstract][Full Text] [Related]
2. Race and medication adherence and glycemic control: findings from an operational health information exchange.
Zhu VJ; Tu W; Marrero DG; Rosenman MB; Overhage JM
AMIA Annu Symp Proc; 2011; 2011():1649-57. PubMed ID: 22195231
[TBL] [Abstract][Full Text] [Related]
3. Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes.
Zhang H; Barner JC; Moczygemba LR; Rascati KL
J Manag Care Spec Pharm; 2020 Nov; 26(11):1434-1444. PubMed ID: 33119450
[No Abstract] [Full Text] [Related]
4. Impact on glycated haemoglobin of a biological response-based measure of medication adherence.
Nichols GA; Rosales AG; Kimes TM; Tunceli K; Kurtyka K; Mavros P; Steiner JF
Diabetes Obes Metab; 2015 Sep; 17(9):843-8. PubMed ID: 25880136
[TBL] [Abstract][Full Text] [Related]
5. Metformin adherence in patients with type 2 diabetes and its association with glycated haemoglobin levels.
Chepulis L; Mayo C; Morison B; Keenan R; Lao C; Paul R; Lawrenson R
J Prim Health Care; 2020 Dec; 12(4):318-326. PubMed ID: 33349319
[TBL] [Abstract][Full Text] [Related]
6. Predictive Validity of Self-Reported Measures of Adherence to Noninsulin Antidiabetes Medication against Control of Glycated Hemoglobin Levels.
Zongo A; Guénette L; Moisan J; Grégoire JP
Can J Diabetes; 2016 Feb; 40(1):58-65. PubMed ID: 26507401
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Study on the Impact of Adherence in Achieving Glycemic Goals in Type 2 Diabetes Mellitus Patients Receiving Canagliflozin.
Buysman EK; Anderson A; Bacchus S; Ingham M
Adv Ther; 2017 Apr; 34(4):937-953. PubMed ID: 28251556
[TBL] [Abstract][Full Text] [Related]
8. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
[TBL] [Abstract][Full Text] [Related]
9. The Change in HbA1c Associated with Initial Adherence and Subsequent Change in Adherence among Diabetes Patients Newly Initiating Metformin Therapy.
Nichols GA; Rosales AG; Kimes TM; Tunceli K; Kurtyka K; Mavros P
J Diabetes Res; 2016; 2016():9687815. PubMed ID: 27579326
[TBL] [Abstract][Full Text] [Related]
10. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
[TBL] [Abstract][Full Text] [Related]
11. Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes.
Bogner HR; de Vries HF; O'Donnell AJ; Morales KH
Am J Manag Care; 2013 Mar; 19(3):e85-92. PubMed ID: 23534947
[TBL] [Abstract][Full Text] [Related]
12. Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.
Farmer AJ; Rodgers LR; Lonergan M; Shields B; Weedon MN; Donnelly L; Holman RR; Pearson ER; Hattersley AT
Diabetes Care; 2016 Feb; 39(2):258-263. PubMed ID: 26681714
[TBL] [Abstract][Full Text] [Related]
13. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
[TBL] [Abstract][Full Text] [Related]
14. Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study.
Lee CS; Tan JHM; Sankari U; Koh YLE; Tan NC
BMJ Open; 2017 Sep; 7(9):e016317. PubMed ID: 28912194
[TBL] [Abstract][Full Text] [Related]
15. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Oladapo AO; Barner JC; Rascati KL; Strassels SA
Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
[TBL] [Abstract][Full Text] [Related]
16. Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database.
Tanabe M; Motonaga R; Terawaki Y; Nomiyama T; Yanase T
J Diabetes Investig; 2017 Mar; 8(2):227-234. PubMed ID: 27549920
[TBL] [Abstract][Full Text] [Related]
17. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study.
Buysman EK; Liu F; Hammer M; Langer J
Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470
[TBL] [Abstract][Full Text] [Related]
18. Medication adherence and associated hemoglobin A1c in type 2 diabetes.
Krapek K; King K; Warren SS; George KG; Caputo DA; Mihelich K; Holst EM; Nichol MB; Shi SG; Livengood KB; Walden S; Lubowski TJ
Ann Pharmacother; 2004 Sep; 38(9):1357-62. PubMed ID: 15238621
[TBL] [Abstract][Full Text] [Related]
19. Refill adherence to oral hypoglycemic agents and glycemic control in veterans.
Kim N; Agostini JV; Justice AC
Ann Pharmacother; 2010 May; 44(5):800-8. PubMed ID: 20388863
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal effects of medication nonadherence on glycemic control.
Egede LE; Gebregziabher M; Echols C; Lynch CP
Ann Pharmacother; 2014 May; 48(5):562-70. PubMed ID: 24586059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
